News Website

Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now - Black Doctor

Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now Black Doctor

Published: Sept. 9, 2026, 8:33 p.m.

Read Full Article

Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now - blackdoctor.com

Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now blackdoctor.com

Published: Sept. 9, 2026, 8:33 p.m.

Read Full Article

Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain - Patient Care Online

Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain Patient Care Online

Published: Aug. 26, 2026, 6:39 p.m.

Read Full Article

Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain - Contemporary OB/GYN

Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain Contemporary OB/GYN

Published: Aug. 26, 2026, 12:20 p.m.

Read Full Article

The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN

The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years MSN

Published: June 8, 2026, 8:37 p.m.

Read Full Article

Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical

Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients News-Medical

Published: May 30, 2026, 2:16 a.m.

Read Full Article

"I live in hospital, week after week after week after week.” That has been Andreea Corden’s life for years. Now 40-years-old, she has spent decades in and out of hospital, with a devastating combination of illnesses. Andreea has Addison’s disease, alongside st - facebook.com

"I live in hospital, week after week after week after week.” That has been Andreea Corden’s life for years. Now 40-years-old, she has spent decades in and out of hospital, …

Published: March 9, 2026, 7:09 a.m.

Read Full Article

GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds - Pharmacy Times

GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds Pharmacy Times

Published: Feb. 13, 2026, 5:09 p.m.

Read Full Article

New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial - geneonline.com

New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial geneonline.com

Published: Dec. 21, 2025, 12:34 p.m.

Read Full Article

Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer - Cancer Nursing Today

Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer Cancer Nursing Today

Published: Dec. 15, 2025, 8:24 p.m.

Read Full Article

Latest Articles

Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now - Black Doctor

Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now - blackdoctor.com

Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain - Patient Care Online

Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain - Contemporary OB/GYN

The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN

Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical

"I live in hospital, week after week after week after week.” That has been Andreea Corden’s life for years. Now 40-years-old, she has spent decades in and out of hospital, with a devastating combination of illnesses. Andreea has Addison’s disease, alongside st - facebook.com

GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds - Pharmacy Times

New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial - geneonline.com

Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer - Cancer Nursing Today

Subscribe to Our Newsletter